Paola Facchetti
Istituto Giannina Gaslini
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Paola Facchetti.
Journal of Immunology | 2000
Irma Airoldi; Giorgia Gri; Jason D. Marshall; Anna Corcione; Paola Facchetti; Roberta Guglielmino; Giorgio Trinchieri; Vito Pistoia
IL-12 activates murine and human B cells, but little information is available as to the expression and function of IL-12R on human B lymphocytes. Here we show that the latter cells, freshly isolated from human tonsils, expressed the transcripts of both β1 and β2 chains of IL-12R and that β2 chain mRNA was selectively increased (4- to 5-fold) by incubation with Staphylococcus aureus Cowan I bacteria or IL-12. B cell stimulation with IL-12 induced de novo expression of the transcripts of the two chains of IL-18R, i.e., IL-1 receptor-related protein and accessory protein-like. Functional studies showed that both IL-12 and IL-18 signaled to B cells through the NF-κB pathway. In the case of IL-12, no involvement of STAT transcription factors, and in particular of STAT-4, was detected. c-rel and p50 were identified as the members of NF-κB family involved in IL-12-mediated signal transduction to B cells. IL-12 and IL-18 synergized in the induction of IFN-γ production by tonsillar B cells, but not in the stimulation of B cell differentiation, although either cytokine promoted IgM secretion in culture supernatants. Finally, naive but not germinal center or memory, tonsillar B cells were identified as the exclusive IL-12 targets in terms of induction of NF-κB activation and of IFN-γ production.
Journal of Immunology | 2000
Ignazia Prigione; Paola Facchetti; Laurence Lecordier; Didier Deslée; Sabrina Chiesa; Marie-France Cesbron-Delauw; Vito Pistoia
Excreted-secreted Ags (ESA) of Toxoplasma gondii (Tg) play an important role in the stimulation of the host immune system in both acute and chronic infections. To identify the parasite Ag(s) involved in the maintenance of T cell-mediated long term immunity, 40 ESA-specific T cell clones were derived from three chronically infected healthy subjects. All the clones were CD4+ and recognized both ESA and live tachyzoites in a HLA-DR-restricted manner. Conversely, CD4+ tachyzoite-specific T cell clones from the same subjects proliferated in response to ESA, pointing to shared immunodominant Ags between ESA and Tg tachyzoites. By T cell blot analysis using SDS-PAGE-fractionated parasite extracts, the following patterns of reactivity were detected. Of 25 clones, 6 recognized Tg fractions in the 24- to 28-kDa range and proliferated to purified GRA2, 5 reacted with Tg fractions in the 30- to 33-kDa range; and 4 of them proved to be specific for rSAg1. Although surface Ag (SAg1) is not a member of ESA, small amounts of this protein were present in ESA preparation by Western blot. Of 25 clones, 8 responded to Tg fractions in the 50- to 60-kDa range but not to the 55-kDa recombinant rhoptries-2 parasite Ag, and 6 did not react with any Tg fraction but proliferated in response to either ESA or total parasite extracts. In conclusion, CD4+ T cells specific for either ESA (GRA2) or SAg1 may be involved in the maintenance of long term immunity to Tg in healthy chronically infected individuals.
Annals of the Rheumatic Diseases | 1996
Marco Gattorno; Paolo Picco; Antonella Buoncompagni; Franca Stalla; Paola Facchetti; Maria Pia Sormani; Vito Pistoia
OBJECTIVE: To determine the expression of tumour necrosis factor alpha (TNF alpha) and its soluble receptors (p55 and p75) in the sera and synovial fluid of patients with juvenile chronic arthritis (JCA), and their correlation with disease activity parameters. METHODS: Ninety eight sera from 45 patients with JCA (14 systemic, 12 polyarticular, 19 pauciarticular), 20 sera from age matched healthy controls, and five synovial fluids from five antinuclear antibody (ANA) positive pauciarticular JCA patients were tested for the presence of TNF alpha, soluble TNF receptors p55 and p75 (sTNFRp55, sTNFRp75), and interleukin-6 (IL-6) by an enzyme amplified sensitivity immunoassay. Physician global estimate of disease activity, weekly fever score and joint score, C reactive protein (CRP), erythrocyte sedimentation rate (ESR), and haemoglobin concentration were evaluated as parameters of disease activity. The expression of p55 and p75 on peripheral mononuclear cells (MNCs) from five patients with systemic JCA and synovial MNCs from five ANA positive patients with pauciarticular JCA was evaluated by flow cytometry. RESULTS: TNF alpha serum concentrations did not differ significantly between the patients with active JCA and the control group. No correlation was found between TNF alpha and parameters of disease activity, but both p55 and p75 showed a significant positive correlation with the physician global estimate of disease activity (p < 0.001), ESR (p < 0.001), CRP (p < 0.001), and serum concentrations of IL-6 (p < 0.001). Serum concentrations of haemoglobin correlated inversely with the concentrations of p55 and p75 (p < 0.001). Synovial lymphocytes selectively expressed the p75 surface receptor. CONCLUSIONS: sTNFRp55 and sTNFRp75 each represent a sensitive marker of disease activity in JCA. Their increased expression in biological fluids may support the hypothesis that TNF alpha has a role in the pathogenesis of JCA.
Cancer Immunology, Immunotherapy | 1996
Paola Facchetti; Ignazia Prigione; Fabio Ghiotto; Paola Tasso; Alberto Garaventa; Vito Pistoia
Abstract Neuroblastoma (NB) is a major-histocompatibility-complex(MHC)-negative neuroectodermal tumour that is often infiltrated with lymphocytes. A detailed characterization of NB-associated tumour-infiltrating lymphocytes (TIL) has never been carried out. Here we have investigated the immunophenotype and the cytotoxic activities of TIL from nine and seven NB patients respectively. Furthermore, the T cell receptor (TcR) variability and the patterns of cytokine gene expression of fresh versus recombinant (r) interleukin(IL)-2-cultured TIL were studied in four NB cases. The results obtained showed the following: (1) freshly isolated TIL were comprised of a mixture of CD4+ and CD8+ T cells partially expressing HLA-DR and/or CD25. The CD4/CD8 ratio ranged from 0.5 to 5 in the different cases. Upon culture of TIL with rIL-2, an increased proportion of CD56+ and CD8+ lymphocytes was consistently observed; (2) IL-2-expanded TIL lysed natural-killer(NK)-sensitive and lymphokine-activated-killer (LAK)-sensitive target cell lines; (3) reverse-transcriptase/polymerase-chain-reaction (RT-PCR) experiments showed that most TcR Vβ genes were expressed both in fresh and in cultured TIL, suggesting that such cell populations were polyclonal; (4) interferon γ, IL-4, IL-5, tumour necrosis factor (TNF) α, IL-8, IL-10 mRNA and, to a lesser extent, IL-2 mRNA were expressed by cultured TIL, as assessed by RT-PCR; the corresponding tumour samples consistently contained TNFα, IL-8 and IL-10 mRNA, whereas IL-2 and IFNγ mRNA were faintly expressed in some NB tumors and IL-4 and IL-5 mRNA were never detected. A total of 90 clones were subsequently raised from IL-2-expanded TIL from six NB patients; 87/90 clones were of T cell lineage with a CD4+ or CD8+ immunophenotype, whereas the 3 remaining clones were of NK cell origin. Upon triggering of the CD3-TcR complex, 64% CD4+ and 77% CD8+ T cell clones killed the murine P815 mastocytoma cell line. Virtually no T cell clone lysed a LAK-sensitive NB cell line, whereas 15% CD4+ and 17% CD8+ clones mediated NK-like activity against the K562 cell line. Finally, the patterns of cytokine production by CD4+ clones were roughly consistent with those of a T helper (Th)1 profile and similar to those observed in CD8+ clones.
The Journal of Allergy and Clinical Immunology | 1998
Alessandro Plebani; Maddalena Stringa; Ignazia Prigione; Paola Facchetti; Fabio Ghiotto; Irma Airoldi; Raffaella Giacchino; Emilio Cristina; Fulvio Porta; Carlo E. Grossi; Vito Pistoia
1. Street MD, Donovan GR, Baldo BA, Sutherland S. Immediate allergic reactions to Myrmecia ant stings; immunochemical analysis of Myrmecia venoms. Clin Exp Allergy 1994;24:590-7. 2. Donovan GR, Baldo BA, Sutherland S. Molecular cloning and characterisation of a major allergen (Myr p 1) from the venom of the Australian jumper ant. Biochim Biophys Acta 1993;1171:272-80. 3. Weiner JM, Baldo BA, Donovan GR, Sutherland SK. Allergy to jumper ant (Myrmecia pilosula) stings in south-eastern Australia [abstract]. Ann Allergy Asthma Immunol 1995;74:60. 4. Stuckey M, Cobain T, Sears M, Cheney J, Dawkins RL. Bee venom hypersensitivity in Busselton [letter]. Lancet 1982;2:41.
Cancer Immunology, Immunotherapy | 1993
Ignazia Prigione; Paola Facchetti; Edoardo Lanino; Alberto Garaventa; Vito Pistoia
In this study we have investigated, at the population and the clonal levels, the immunophenotypes and the non-specific cytotoxic functions of peripheral blood lymphocytes from three stage IV neuroblastoma patients receiving treatment with recombinant interleukin-2 (IL-2) and interferon α (IFNα). Both IL-2 alone and the combination of IL-2 and IFNα caused an in vivo expansion of CD56+, CD3− NK cells most of which expressed the p75 molecule, i.e. the β chain of the IL-2 receptor. Peripheral blood mononuclear cells (PBMC), drawn after treatment, displayed an increased NK activity, but no lymphokine-activated killer (LAK) activity. However, the subsequent in vitro culture of PBMC with high-dose IL-2 induced the generation of a potent LAK activity, which was mediated by an expanded population of CD3+ CD8+ T cells. Finally lymphocytes that had been isolated after cytokine therapy were cloned, in the presence of low-dose phytohemagglutin, immediately or following culture with IL-2. Clones derived from LAK cells expanded in vitro had predominantly a CD3+, CD8+ immunophenotype, whereas those raised from freshly separated lymphocytes were either CD3+, CD4+ or CD3+, CD8+ in equal proportions. Most of the above clones were poorly or not at all cytolytic against NK-sensitive or NK-resistant targets. In contrast, the few NK clones obtained (CD3−, CD56+) lysed all targets with high efficiency.
Journal of the National Cancer Institute | 2000
Anna Corcione; Luciano Ottonello; Giuseppe Tortolina; Paola Facchetti; Irma Airoldi; Roberta Guglielmino; Patrizia Dadati; Mauro Truini; Silvano Sozzani; Franco Dallegri; Vito Pistoia
European Journal of Immunology | 1995
Ignazia Prigione; Paola Facchetti; Fabio Ghiotto; Paola Tasso; Vito Pistoia
The Journal of Rheumatology | 1998
Paolo Picco; Marco Gattorno; Antonella Buoncompagni; Paola Facchetti; Giovanna Rossi; Vito Pistoia
Cancer Research | 2001
Irma Airoldi; Roberta Guglielmino; Fabio Ghiotto; Anna Corcione; Paola Facchetti; Mauro Truini; Vito Pistoia